Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by the presence of the Philadelphia chromosome, a reciprocal translocation between chromosomes 9 and 22 resulting in the BCR-ABL1 fusion gene. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.